We synthesized a series of enediyne containing Combretastatin A-4 analogues and evaluated the growth inhibitory activity of analogues against two human hepatoma cell lines (Hep G2, Hep 3B), two breast cancer cell lines (MDA-MB-231, MCF-7) and human lung cancer cell line (A-549). It was found that compounds 39a, 39d, 39e, 39f and 40a produced growth inhibitory activity for the five human cancer cell lines. Among them, compound 40a showed the best inhibitory activity (IC50 = 0.8 £gM for A-549 and IC50 = 8.53 £gM for Hep 3B) which were comparable to the Combretastatin A-4 (IC50 = 1.57 £gM for A-549 and IC50 = 14.32 £gM for Hep 3B).
| Identifer | oai:union.ndltd.org:NSYSU/oai:NSYSU:etd-0706111-163900 |
| Date | 06 July 2011 |
| Creators | Huang, I-Hua |
| Contributors | Tzeng, Cherng-Chyi, Wu, Ming-Jung, Ong, Chi-Wi |
| Publisher | NSYSU |
| Source Sets | NSYSU Electronic Thesis and Dissertation Archive |
| Language | Cholon |
| Detected Language | English |
| Type | text |
| Format | application/pdf |
| Source | http://etd.lib.nsysu.edu.tw/ETD-db/ETD-search/view_etd?URN=etd-0706111-163900 |
| Rights | not_available, Copyright information available at source archive |
Page generated in 0.0017 seconds